Küldje el az oldalt ismerősének!
RSS
google +
Nyomtatóbarát változat

Hírek (Antibiotikum-rezisztencia)

This section on health in the EU has been created as a trustworthy gateway to a wide range of information and data on health-related issues and activities at both European, national and international level. The content is produced by the European Commission, the Member States of the EU and the European Economic Area (EEA), plus EU candidate countries; by international organisations; and by pan-European non-governmental organisations in the area of public health.

Contributions invited to develop global action plan on antimicrobial resistance    who.int

WHO is leading the development of a global action plan to address antimicrobial resistance (AMR), as requested by the Sixty-seventh World Health Assembly in May 2014.[...]

European Commission launches logo for online pharmacies to protect patients from falsified medicines    europa.eu

Today the European Commission has introduced a logo that will allow patients to identify authorised online pharmacies providing authentic medicines.[...]

Eurobarometer on patient safety and quality of care    europa.eu

European Commission - The objective of this survey was to review changes that had occurred since the adoption of the Council Recommendation on patient safety and healthcare associated inf[...]

Commission’s second implementation report on patient safety, including the prevention and control of healthcare associated infections    europa.eu

European Commission - A patient safety package published on 19 June 2014 by the European Commission highlights how the Commission and EU countries are addressing the challenge of patient [...]

Patient safety: progress made, more needed    europa.eu

A patient safety package published by the European Commission highlights how the Commission and EU countries are addressing the challenge of patient safety, progress made since 2012 and barriers to o[...]

Scientific guideline: Draft reflection paper on the use of patient reported outcome (PRO) measures in oncology studies, draft: consultation open    europa.eu

The importance of the patient's point of view on their health status is fully acknowledged and such information may in principle be used in drawing regulatory conclusions regarding treatment effects.[...]

Patient Information launches first onco-urological topic: kidney cancer    uroweb.org

EAU Patient Information has reached a veritable milestone with the launch of the first onco-urological information set. The series on kidney cancer offers medical information about diagnosis and trea[...]

Call for comprehensive inclusion of patient reported outcomes in cardiovascular clinical trials    escardio.org

Patient reported outcomes (PROs) should be comprehensively included in cardiovascular clinical trials using the best available tools, according to leading cardiologists and industry representatives i[...]

EFA Patients will discuss at the European Parliament    efanet.org

Benefits of EU research on allergy, asthma and COPD On June 17th 2014, EFA invites all stakeholders interested in ongoing EU-funded research initiatives for allergy, asthma and COPD to the European P[...]

Families waiting to return to their homes following Bosnia floods    ifrc.org

Following devastating floods, many families are staying in Red Cross evacuation centres until the water levels drop.[...]

World Health Assembly closes: resolution on antimicrobial resistance approved    who.int

The Sixty-seventh World Health Assembly closed on Saturday 24 May 2014, after adopting more than 20 resolutions on public health issues of global importance.[...]

Every day should be patients' rights day    epha.org

Active Citizenship Network (ACN) decided to dedicate the 8th celebration of European Patients' Rights Day in 2014 to [...]

IN-TIME shows equal benefit of home telemonitoring in ICD and CRT-D patients    escardio.org

Home telemonitoring is equally effective in ICD and CRT-D patients, a subanalysis of the IN-TIME trial has shown. The multicentre trial included 664 patients with chronic heart failure, class II or I[...]

How could emergency care be improved for patients with acute heart failure?    escardio.org

Welcome to the European Society of Cardiology . Our mission: to reduce the burden of cardiovascular disease in Europe Professor Sean Collins Represents the Society for Academic Emergency Medicine Va[...]

Sleeping pills increase CV events in heart failure patients    escardio.org

Sleeping pills increase the risk of cardiovascular events in heart failure patients by 8-fold, according to research from Japan. Dr Masahiko Setoguchi said: [...]

Transatlantic Taskforce on Antimicrobial Resistance reports progress and outcomes of 17 recommendations    europa.eu

The European Commission and the US Department of Health and Human Services have published today a progress report of the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR).[...]

Commissioner Tonio Borg delivers a message to patients on the occasion of European Patients’ Rights Day    europa.eu

European Commission - Press Release details page - European Commission Statement Brussels, 12 May 2014 [...]

European Patients' Rights Day: 10 benefits the EU brings to patients    europa.eu

European Commission - Press Release details page - Commission MEMO Brussels, 12 May 2014 European A high level of health protection; the right to benefit from medical treatment; access to healthcare[...]

Success Stories - Improving medical implants to enhance the health of patients    europa.eu

Medical implants have helped save or improve countless lives. From heart valves and artificial joints, to bone plates and stents for blood vessels, these biomedical implants have revolutionised medic[...]

Cross-Border Healthcare in Europe: Improving Co-operation to Deliver a Patient-Centred System    eugms.org

The EU Directive on Patients' Rights in Cross-Border Healthcare seeks to eliminate obstacles hindering patients from receiving treatment in another Member State. Rules for receiving cross-border heal[...]

UNFPA - UNFPA, Bill & Melinda Gates Foundation to Boost Family Planning in Developing Countries    unfpa.org

The agreement will draw on both organizations’ strengths and expertise in support of the global goal of expanding access to high-quality, voluntary family planning supplies and services for an addit[...]

UNFPA - UNFPA, Bill & Melinda Gates Foundation to Boost Family Planning in Developing Countries    unfpa.org

The agreement will draw on both organizations’ strengths and expertise in support of the global goal of expanding access to high-quality, voluntary family planning supplies and services for an addit[...]

Statement on MERS-CoV infection advice with regard to travelling and for Health Care Workers caring for patients with confirmed or possible MERS-CoV infection    europa.eu

European Commission - According to Decision 1082/2013/EU on serious cross border health threats, the EU Member States consult each other within the Health Security Committee (HSC) and in [...]

Eplerenone reduces primary endpoint in acute myocardial infarction patients    escardio.org

A drug known to reduce mortality rate in patients with heart failure has now been found significantly effective when administered early in patients following an acute (ST elevated) myocardial infarct[...]

EHC WorldHaemophiliaDay event showed that much remains to be done to achieve minimum standards of haemophilia treatment    edqm.eu

24 April 2014 EHC World Haemophilia Day event 16 April 2014, Wildbad Kreuth On 16 April, the European Haemophilia Consortium organised a meeting at the Paul-Ehrlich-Institute to present the EDQM reco[...]

Keeping Antimicrobial Resistance (AMR) on the radar screen, year-round    epha.org

The global problem of Antimicrobial Resistance (AMR) demands the continuous attention of the public health community beyond the annual focus of the European Antibiotic Awareness Day. EPHA is committe[...]

Bulgarian Red Cross helps Syrian family reunite    ifrc.org

Berivan and her cousins were separated from their family during the dangerous crossing from Turkey into Bulgaria. A month and a half later the Bulgarian Red Cross helped the Syrian family reunite.[...]

Questions & Answers: Fees for Pharmacovigilance activities - Press release    europa.eu

European Commission - Press Release details page - European Commission MEMO Brussels, 16 April 2014 Today, the European Parliament voted in favour of an EU Regulation on fees payable to the European[...]

UNFPA - UNFPA, Bill & Melinda Gates Foundation to Boost Family Planning in Developing Countries    unfpa.org

The agreement will draw on both organizations’ strengths and expertise in support of the global goal of expanding access to high-quality, voluntary family planning supplies and services for an addit[...]

UNFPA - UNFPA, Bill & Melinda Gates Foundation to Boost Family Planning in Developing Countries    unfpa.org

The agreement will draw on both organizations’ strengths and expertise in support of the global goal of expanding access to high-quality, voluntary family planning supplies and services for an addit[...]

EMA and EU national competent authorities agree on action plan to address medication errors    europa.eu

The European Medicines Agency and the National Competent Authorities of the European Union (EU) have agreed an action plan to address the issue of medication errors, a major public-health burden.[...]

Access all the presentations from EuroHeartCare 2014    escardio.org

The ESC Council on Cardiovascular Nursing and Allied Professions has made the slides from all EuroHeartcongress presentations available here. Topics: Cardiovascular Nursing[...]

Poor sleep doubles hospitalisations in heart failure patients    escardio.org

Chronic sleep deprivation previously linked to inflammation and higher stress levels according to research presented during EuroHeartCare 2014; Dr Peter Johansson, first author said: [...]

[Press Release] European Parliament takes leap towards patient safety    epha.org

Brussels, 3 April 2014 - EPHA welcomes the majority of the measures adopted yesterday by the European Parliament as part of the revision of the EU Medical Devices Directive (MDD) and the In Vitro Dia[...]

Exercise training improves HDL quality in CHF patients    escardio.org

Nicolle Kraenkel comments on a study by V. Adams et al. (Circulation Research, 2013), suggesting that in patients with severe CHF, exercise training achieves a [...]

Europe for Patients at EP Elections    efanet.org

The European Parliament elections are approaching. In less than two months European citizens will be called to vote on their future representatives in Europe. EFA continues its efforts to share EFA M[...]

EU patient empowerment    efanet.org

This month EFA features activities surrounding patient EU patient empowerment. It features EFA's presentation of patient involvement within the EU project U-BIOPRED at a conference on patient empower[...]

[EPHA answer] Public consultation on patient safety and quality of care    epha.org

In December 2013, the European Commission launched a public consultation on patient safety and quality of care in the EU, which ran until the end of February 2014. As Europe's leading NGO advocating [...]

Antimicrobial resistance remains commonly detected in bacteria in humans, animals and food:...    europa.eu

Antimicrobial resistance remains commonly detected in bacteria in humans, animals and food:...[...]

Infographic: Europe’s fight against antimicrobial resistance    europa.eu

Published on: 25 March 2014 The fourth joint EFSA and ECDC report on antimicrobial resistance in zoonotic bacteria affecting humans, animals and foods. The report is based on data collected by EU Mem[...]

Antimicrobial resistance remains commonly detected in bacteria in humans, animals and food: EFSA -ECDC report    europa.eu

Published on: 25 March 2014 Bacteria most frequently causing food-borne infections, such as Salmonella and Campylobacter, show significant resistance to common antimicrobials, according to the EFSA-E[...]

Periodic Report Summary - INFBIOSYS (The role of Bacterial Multigene Families in Infection: Identification of Host Target Networks by High-throughput Protein Interactomics)    europa.eumsw8

THE UNIVERSITY OF EDINBURGH The genomes of pathogenic bacteria often contain multiple copies of genes with similar sequence, thus forming what is known as a multigene family. Multigene families arise[...]

Final Report Summary - INFBIOSYS (The role of Bacterial Multigene Families in Infection: Identification of Host Target Networks by High-throughput Protein Interactomics)    europa.eumsw8

THE UNIVERSITY OF EDINBURGH The genomes of pathogenic bacteria often contain multiple copies of genes with similar sequence, thus forming what is known as a multigene family. Multigene families arise[...]

World TB Day – three new medicines recommended in last six months for patients with multidrug-resistant tuberculosis    europa.eu

Tuberculosis is an infection caused by Mycobacterium tuberculosis that primarily affects the lungs.[...]

Prof. Thorsten Bach appointed EAU Patient Information Consultant    uroweb.org

Prof. Thorsten Bach (Hamburg, DE) has been appointed EAU Patient Information Consultant. In this newly created function within the European School of Urology (ESU), Bach will focus on encouraging par[...]

Scientific guideline: Draft guideline on the evaluation of the pharmacokinetics of medicinal products in patients with decreased renal function, draft: consultation open    europa.eu

Pharmacokinetic studies can be used to estimate drug exposure in subpopulations of patients with characteristics that might affect the pharmacokinetics of the drug, and alternative dosing regimens ma[...]

EFA Training on EMA    efanet.org

EFA training for patient experts on allergy, asthma and COPD on getting involved with the European Medicines Agency (EMA) As we informed you in the last issue of our eZine, EFA planned to host on 18t[...]

Rare Disease Day 2014 – twelve new orphan medicines available to patients over the past year    europa.eu

Over the past twelve months, a total of 12 medicines for the treatment of rare diseases were recommended for marketing authorisation by the European Medicines Agency's (EMA) Committee for Medicinal P[...]

Disclaimer

The European Commission is solely responsible for information present on EU-level websites, information present in the Portal originated by the Commission. National-level information is provided by the Member States concerned and Member States are solely responsible for the accuracy of the information. Likewise, the European Commission is not responsible for information on non-governmental organisations and international organisations websites. The European Union is committed to user privacy. Read more concerning the Legal Notice.
Further questions can be answered through the Contact page. The Health-EU portal supports principles and measures to increase the credibility of information on the net. It complies with the HONcode standard for trustworthy health information: verify here.